University of Florida researchers now believe they have discovered an idea that might ultimately lead to an effective ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla ...

Neurelis, Inc., today announced details of three poster presentations at the American Academy of Neurology (AAN) Annual ...